共 47 条
The endoplasmic reticulum-associated Hsp40 DNAJB12 and Hsc70 cooperate to facilitate RMA1 E3-dependent degradation of nascent CFTRΔF508
被引:106
作者:
Grove, Diane E.
Fan, Chun-Yang
Ren, Hong Yu
Cyr, Douglas M.
[1
]
机构:
[1] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA
基金:
美国国家卫生研究院;
关键词:
TRANSMEMBRANE CONDUCTANCE REGULATOR;
DOWN-REGULATION;
CFTR;
DOMAIN;
MATURATION;
PROTEASOME;
PROMOTES;
BINDING;
MUTANT;
DELTA-F508-CFTR;
D O I:
10.1091/mbc.E10-09-0760
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
Relative contributions of folding kinetics versus protein quality control (QC) activity in the partitioning of non-native proteins between life and death are not clear. Cystic fibrosis transmembrane conductance regulator (CFTR) biogenesis serves as an excellent model to study this question because folding of nascent CFTR is inefficient and deletion of F508 causes accumulation of CFTR Delta F508 in a kinetically trapped, but foldable state. Herein, a novel endoplasmic reticulum (ER)-associated Hsp40, DNAJB12 (JB12) is demonstrated to play a role in control of CFTR folding efficiency. JB12 cooperates with cytosolic Hsc70 and the ubiquitin ligase RMA1 to target CFTR and CFTR Delta F508 for degradation. Modest elevation of JB12 decreased nascent CFTR and CFTR Delta F508 accumulation while increasing association of Hsc70 with ER forms of CFTR and the RMA1 E3 complex. Depletion of JB12 increased CFTR folding efficiency up to threefold and permitted a pool of CFTR Delta F508 to fold and escape the ER. Introduction of the V510D misfolding suppressor mutation into CFTR Delta F508 modestly increased folding efficiency, whereas combined inactivation of JB12 and suppression of intrinsic folding defects permitted CFTR Delta F508 to fold at 50% of wild-type efficiency. Therapeutic correction of CFTR Delta F508 misfolding in cystic fibrosis patients may require repair of defective folding kinetics and suppression of ER QC factors, such as JB12.
引用
收藏
页码:301 / 314
页数:14
相关论文